Anti-angiogenic therapy and chemotherapy affect 99mtc sestamibi and 99mtc-hl91 accumulation differently in tumour xenografts

Nuclear Medicine Communications

Volumn 26, Issue 12, 2005, Pages 1067-1073

  Kinuya, Seigo ^a   Yokoyama, Kunihiko ^b   Fukuoka, Makoto ^c   Mori, Hirofumi ^c   Shiba, Kazuhiro ^c   Watanabe, Naoto ^c   Shuke, Noriyuki ^c   Michigishi, Takatoshi ^c   Tonami, Norihisa ^c  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Anti angiogenic therapy; Chemotherapy; Therapeutic responses

Indexed keywords

2 METHOXYESTRADIOL; FLUOROURACIL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OXYGEN; TRACER; UPENAZIME TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; COLON CANCER; CYTOTOXICITY; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MICROELECTRODE; MOUSE; NONHUMAN; OXYGEN ELECTRODE; OXYGEN TENSION; TUMOR; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; CELL LINE, TUMOR; ESTRADIOL; FLUOROURACIL; HUMANS; KINETICS; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; ORGANOTECHNETIUM COMPOUNDS; OXIMES; OXYGEN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS;

EID: 27944454439     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200512000-00004     Document Type: Article

References (31)

1. Giannopoulou C. The role of SPET and PET in monitoring tumor response to therapy. Eur J Nucl Med Mol Imaging 2003; 30:1173-1200.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1:27-31.
3. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ. Inhibition of angio genesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 1997; 57:81-86.
4. Tsukamoto A, Kaneko Y, Yoshida T, Han K, Ichinose M, Kimura S. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells. Biochem Biophys Res Commun 1998; 248:9-12.
5. Reiser F, Way D, Bernas M, Witte M, Witte C. Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol. Proc Soc Exp Biol Med 1998; 219:211-216.
6. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003; 23:165-172.
7. Ballinger JR. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein. Cancer Biother Radiopharm 2001; 16:1-7.
8. 99mTc-tetrofosmin. Ann Nucl Med 2004; 18:79-95.
9. Kinuya S, Kawashima A, Yokoyama K, Kudo M, Kasahara Y, Watanabe H, et al. Antiangiogenic therapy and radioimmunotherapy in colon cancer xenografts. Eur J Nucl Med 2001; 28:1306-1312.
10. Li X-F, Kinuya S, Yokoyama K, Koshida K, Mori H, Shiba K, et al. Benefits of combined radioimmunotherapy and antiangiogenic therapy in a liver metastasis model of human colon cancer cells. Eur J Nucl Med Mol Imaging 2002; 29:1669-1674.
11. Kinuya S, Yokoyama K, Tega H, Hiramatsu T, Konishi S, Watanabe N, et al. Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts. J Cancer Res Clin Oncol 125; 11:630-636.
12. Cook GJ, Houston S, Barrington SF, Fogelman I. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med 1998; 39:99-103.
13. Tatsumi M, Yutani K, Kusuoka H, Nishimura T. Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow. Eur J Nucl Med 1999; 26:91-94.
14. 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo. Int J Radiat Oncol Biol Phys 1998; 42:731-735.
15. 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia. J Nucl Med 1999; 40:854-861.
16. 99mTc-HL91: correlation with microelectrode measurements. J Nucl Med 2001; 42:337-344.
17. 99mTc-HL91. Eur J Nucl Med Mol Imaging 2002; 29:1006-1011.
18. 99mTc-tetrofosmin uptake in MRP1-expressing breast cancer cells under hypoxic conditions is independent of MRP function. Eur J Nucl Med Mol Imaging 2003; 30:1529-1531.
19. Mukhopadhyay T, Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997; 14:379-384.
20. Mukhopadhyay T, Roth JA. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene 1998; 17:241-246.
21. Carothers AM, Hughes SA, Ortega D, Bertagnolli MM. 2-methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells. Cancer Let 2002; 187:77-86.
22. 186Re-labeled monoclonal antibody. J Nucl Med 2001; 42:596-600.
23. Dordunoo SK, Jackson JK, Arsenault LA, Oktaba AM, Hunter WL, Burt HM. Taxol encapsulation in poly(epsilon-caprolactone) microspheres. Cancer Chemother Pharmacol 1995; 36:279-282.
24. Baguley BC, Holdaway KM, Thomsen LL, Zhuang L, Zwi LJ. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism. Eur J Cancer 1991; 27:482-487.
25. Yonekura K, Basaki Ym, Chikahisa L, Okabe S, Hashimoto A, Miyadera K, et al. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin Cancer Res 1999; 5:2185-2191.
26. Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, et al. Blockage of 2-deoxy-D-ribose induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy. Clin Cancer Res 2004; 10:1843-1852.
27. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37:1551-1556.
28. 201Tl in a tumour cell line. Nucl Med Commun 1997; 18:235-240.
29. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998; 39:266-271.
30. Schuetz EG, Beck WT, Schuetz JD. Modulators and substrates of p-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 1996; 49:311-318.
31. Sakata K, Kwok TT, Murphy BJ, Laderoute KR, Gordon GR, Sutherland RM. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 1991; 64:809-814.